Insider · CIK 0001487815
Cui Xiangmin
Reports to the SEC for 9 companies · NEW YORK, NY
Transactions
50
Companies
9
Filings
7
CIK
0001487815
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-21 | NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-02-27 | NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-02-27 | NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-09-04 | NUVBNuvation Bio Inc.C Conversion | — |
| 2024-09-04 | NUVBNuvation Bio Inc.C Conversion | — |
| 2024-09-04 | NUVBNuvation Bio Inc.C Conversion | — |
| 2024-09-04 | NUVBNuvation Bio Inc. · Series A Preferred StockC Conversion | — |
| 2024-09-04 | NUVBNuvation Bio Inc. · Series A Preferred StockC Conversion | — |
| 2024-09-04 | NUVBNuvation Bio Inc. · Series A Preferred StockC Conversion | — |
| 2024-09-03 | NUVBNuvation Bio Inc. · Warrants (Right to Buy)A Award | — |
| 2024-09-03 | NUVBNuvation Bio Inc. · Series A Preferred StockA Award | — |
| 2024-09-03 | NUVBNuvation Bio Inc. · Warrants (Right to Buy)A Award | — |
| 2024-09-03 | NUVBNuvation Bio Inc. · Warrants (Right to Buy)A Award | — |
| 2024-09-03 | NUVBNuvation Bio Inc. · Series A Preferred StockA Award | — |
| 2024-09-03 | NUVBNuvation Bio Inc. · Series A Preferred StockA Award | — |
| 2024-06-25 | NUVBNuvation Bio Inc.P Purchase | +$825K |
| 2024-06-24 | NUVBNuvation Bio Inc.P Purchase | +$1M |
| 2024-06-21 | NUVBNuvation Bio Inc.P Purchase | +$226K |
| 2024-06-20 | NUVBNuvation Bio Inc.P Purchase | +$262K |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-18 | ALPINE IMMUNE SCIENCES, INC.U Disposition from Tender | — |
| 2024-05-18 | ALPINE IMMUNE SCIENCES, INC.U Disposition from Tender | — |
| 2024-04-09 | NUVBNuvation Bio Inc.A Award | — |
| 2024-04-09 | NUVBNuvation Bio Inc.A Award | — |
| 2024-04-09 | NUVBNuvation Bio Inc.A Award | — |
| 2024-01-18 | ALPINE IMMUNE SCIENCES, INC.X Exercise of In-Money | +$15.7M |
| 2024-01-18 | ALPINE IMMUNE SCIENCES, INC.Warrant (right to buy)X Exercise of In-Money | — |
| 2024-01-02 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2023-11-09 | ALPINE IMMUNE SCIENCES, INC.P Purchase | +$4.69M |
| 2023-01-03 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2022-09-23 | ALPINE IMMUNE SCIENCES, INC.A Award | +$4.7M |
| 2022-09-23 | ALPINE IMMUNE SCIENCES, INC.A Award | +$10M |
| 2022-01-03 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2021-09-28 | Cue Health Inc.C Conversion | — |
| 2021-09-28 | Cue Health Inc.Series C-1 Preferred StockC Conversion | — |
| 2021-09-28 | Cue Health Inc.A Award | +$10.1M |
| 2021-09-17 | ALPINE IMMUNE SCIENCES, INC.P Purchase | +$14.5M |
| 2021-01-04 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2020-01-02 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2019-01-18 | ALPINE IMMUNE SCIENCES, INC.A Award | +$17M |
| 2019-01-18 | ALPINE IMMUNE SCIENCES, INC.Warrant (right to buy)A Award | +$6.63M |
| 2019-01-18 | ALPINE IMMUNE SCIENCES, INC.Stock Option (right to buy)A Award | — |
| 2018-06-22 | ARMO BioSciences, Inc.U Disposition from Tender | −$60.7M |
| 2018-06-22 | ARMO BioSciences, Inc.Stock Option (right to buy)D Disposition to Issuer | −$181K |
| 2018-03-26 | ARMO BioSciences, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4/ACui Xiangmin0001487815-26-000006SEC(opens sec.gov)
- 4Cui Xiangmin0001487815-26-000007SEC(opens sec.gov)
- 4Cui Xiangmin0001487815-26-000003SEC(opens sec.gov)
- 4Cui Xiangmin0001415889-24-022899SEC(opens sec.gov)
- 4Cui Xiangmin0001415889-24-018231SEC(opens sec.gov)
- 4Cui Xiangmin0001415889-24-018162SEC(opens sec.gov)
- 4Cui Xiangmin0001626199-24-000095SEC(opens sec.gov)
Companies
- Aardvark Therapeutics, Inc.10% OwnerAARD
- ALPINE IMMUNE SCIENCES, INC.Director, 10% Owner
- ARMO BioSciences, Inc.Director
- BeyondSpring Inc.10% OwnerBYSI
- CG Oncology, Inc.10% OwnerCGON
- China Biologic Products Holdings, Inc.Director
- Cue Health Inc.Director
- Equillium, Inc.10% OwnerEQ
- Nuvation Bio Inc.DirectorNUVB
Address
C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401
NEW YORK, NY, 10036